Adductor Spasmodic Dysphonia Clinical Trial
Official title:
Effects of Vocal Exercise Following Botox Injection on Voice Handicap and Communicative Participation for Adductor Spasmodic Dysphonia
The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.
Spasmodic dysphonia (SD) is a neurological disorder characterized by involuntary spasms of
the vocal folds resulting in a strained and strangled voice quality. This disorder is quite
disabling to patients who suffer from it, particularly affecting patients' quality of life.
Botulinum toxin (Botox) has been found to be the most effective treatment for SD. The Botox
is injected into the affected muscle resulting in temporary weakening of the muscle. The
patients return for injections on average every 3 - 6 months.
There is a suggestion in the literature that increased diffusion of the Botox injectate could
improve the effects of the injection. Furthermore, there is literature supporting the use of
exercise to increase the diffusion of the Botox. Previous research examined the use of
voluntary muscle activity vs. rest immediately following Botox injection for writer's cramp.
It was found that the active condition resulted in greater reduction of muscle strength in
the injected muscle. Another small study of 9 patients implemented intense exercise comprised
of loud reading for one hour and a rest condition of total voice rest for 24 hours. They
found that the exercise condition resulted in improved scores on the voice related-quality of
life (V-RQOL) measure and concluded that improvement in results of Botox injections may be
achieved more consistently with the implementation of exercise following the injection. The
exercise used in this study was intense and may be contrary to the overall benefit as the
subjects may experience phonotrauma. Timing of the exercise post-injection may also be a
factor. Previous literature review revealed combined modality treatment of Botox injection
only, Botox with therapy and Botox with sham treatment. They found no significant differences
in acoustic stability, V-RQOL, or duration of injection benefit. However, the exercise was
initiated 3 weeks post-injection and completed once per week for 5 weeks. Investigators aim
to identify what might improve or extend the duration of botox injections for adductor
Spasmodic dysphonia.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05158166 -
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT03129087 -
The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia
|
N/A | |
Not yet recruiting |
NCT06402214 -
The 'Lombard Effect' in Patients Affected by Adductor Laryngeal Dystonia
|
N/A | |
Completed |
NCT02528006 -
Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05467228 -
Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia
|
Phase 2 | |
Completed |
NCT05158179 -
Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia
|
N/A |